The board of optometry and pharmacy quality assurance commission will use a joint process to determine changes to the oral drug list that includes a means to resolve disagreements.
(1) Categories of medications approved by the Food and Drug Administration may be added to WAC
246-851-580(1) by rule through consultation and approval of the board of optometry and pharmacy quality assurance commission.
(2) Medications approved by the Food and Drug Administration in categories that are within the scope of optometric physician practice that are not included in WAC
246-851-580(1) may be added through consultation and approval of the board of optometry and the pharmacy quality assurance commission. Approval will follow the joint process established by the board and commission.
[Statutory Authority: RCW
18.54.070(2). WSR 14-12-059, § 246-851-610, filed 5/30/14, effective 6/30/14. Statutory Authority: 2003 c 142 and RCW
18.54.070(2). WSR 04-12-127, § 246-851-610, filed 6/2/04, effective 7/3/04.]